Professor Gordon Cook, professor of haematology at the University of Leeds and lead for the myeloma clinical and translational research portfolio and Professor Graham Jackson, consultant haematologist at Newcastle upon Tyne Hospitals NHS Foundation Trust discuss managing toxicities associated with treatment including peripheral neuropathies, cytopenias, cytokine release syndrome and ICANs, as well as cardiac and gastrointestinal complications.